Adagio Medical (NASDAQ:ADGM) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness
Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors
Adagio Medical (NASDAQ:ADGM) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $4.00 price target on the stock.
Adagio Medical (NASDAQ:ADGM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.